Modeling the Novel Coronavirus (SARS-CoV-2) Outbreak in Sicily, Italy

被引:23
|
作者
Maugeri, Andrea [1 ]
Barchitta, Martina [1 ]
Battiato, Sebastiano [2 ]
Agodi, Antonella [1 ,3 ]
机构
[1] Univ Catania, Dept Med & Surg Sci & Adv Technol GF Ingrassia, I-95123 Catania, Italy
[2] Univ Catania, Dept Math & Comp Sci, I-95123 Catania, Italy
[3] Azienda Ospedal Univ Policlin Vittorio Emanue, I-95123 Catania, Italy
关键词
novel coronavirus; COVID-19; epidemic model; epidemiology;
D O I
10.3390/ijerph17144964
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Italy was the first country in Europe which imposed control measures of travel restrictions, quarantine and contact precautions to tackle the epidemic spread of the novel coronavirus (SARS-CoV-2) in all its regions. While such efforts are still ongoing, uncertainties regarding SARS-CoV-2 transmissibility and ascertainment of cases make it difficult to evaluate the effectiveness of restrictions. Here, we employed a Susceptible-Exposed-Infectious-Recovered-Dead (SEIRD) model to assess SARS-CoV-2 transmission dynamics, working on the number of reported patients in intensive care unit (ICU) and deaths in Sicily (Italy), from 24 February to 13 April. Overall, we obtained a good fit between estimated and reported data, with a fraction of unreported SARS-CoV-2 cases (18.4%; 95%CI = 0-34.0%) before 10 March lockdown. Interestingly, we estimated that transmission rate in the community was reduced by 32% (95%CI = 23-42%) after the first set of restrictions, and by 80% (95%CI = 70-89%) after those adopted on 23 March. Thus, our estimates delineated the characteristics of SARS-CoV2 epidemic before restrictions taking into account unreported data. Moreover, our findings suggested that transmission rates were reduced after the adoption of control measures. However, we cannot evaluate whether part of this reduction might be attributable to other unmeasured factors, and hence further research and more accurate data are needed to understand the extent to which restrictions contributed to the epidemic control.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [21] Biology of the SARS-CoV-2 Coronavirus
    Rimma N. Mingaleeva
    Nigina A. Nigmatulina
    Liliya M. Sharafetdinova
    Albina M. Romozanova
    Aida G. Gabdoulkhakova
    Yuliya V. Filina
    Rafael F. Shavaliyev
    Albert A. Rizvanov
    Regina R. Miftakhova
    Biochemistry (Moscow), 2022, 87 : 1662 - 1678
  • [22] Biology of the SARS-CoV-2 Coronavirus
    Mingaleeva, Rimma N.
    Nigmatulina, Nigina A.
    Sharafetdinova, Liliya M.
    Romozanova, Albina M.
    Gabdoulkhakova, Aida G.
    Filina, Yuliya V.
    Shavaliyev, Rafael F.
    Rizvanov, Albert A.
    Miftakhova, Regina R.
    BIOCHEMISTRY-MOSCOW, 2022, 87 (12-13) : 1662 - 1678
  • [23] Properties of Coronavirus and SARS-CoV-2
    Malik, Yasmin A.
    MALAYSIAN JOURNAL OF PATHOLOGY, 2020, 42 (01) : 3 - 11
  • [24] Textiles and coronavirus (SARS-CoV-2)
    Lee, Davis
    Kirkpatrick, Erin
    Gladman, A. Sydney
    Fitzharris, Emily
    Posson, Michael
    Roberts, Mark
    Textiles Panamericanos, 2020, 80 (03):
  • [25] Textiles & The Coronavirus (SARS-CoV-2)
    Lee, Davis
    Kirkpatrick, Erin
    Gladman, Sydney
    Fitzharris, Emily
    Posson, Michael
    Roberts, Mark
    Textile World, 2020, 2020 (May-June)
  • [26] The impact of the SARS-CoV-2 outbreak on the safety and availability of blood transfusions in Italy
    Franchini, Massimo
    Farrugia, Albert
    Velati, Claudio
    Zanetti, Alessandro
    Romano, Luisa
    Grazzini, Giuliano
    Lopez, Nadia
    Pati, Ilaria
    Marano, Giuseppe
    Pupella, Simonetta
    Liumbruno, Giancarlo Maria
    VOX SANGUINIS, 2020, 115 (08) : 603 - 605
  • [27] The bimodal SARS-CoV-2 outbreak in Italy as an effect of environmental and allergic causes
    Chirumbolo, Salvatore
    Bjorklund, Geir
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 146 (02) : 331 - 332
  • [28] Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2)
    Yangyang Cai
    Yinghui Xu
    Dongsheng Xu
    Yizhuo Wang
    Xu Wang
    Chao Sun
    Ye Guo
    Shi Qiu
    Kewei Ma
    Medical Oncology, 2020, 37
  • [29] Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2)
    Cai, Yangyang
    Xu, Yinghui
    Xu, Dongsheng
    Wang, Yizhuo
    Wang, Xu
    Sun, Chao
    Guo, Ye
    Qiu, Shi
    Ma, Kewei
    MEDICAL ONCOLOGY, 2020, 37 (09)
  • [30] Outbreak of Novel Coronavirus (SARS-CoV-2): First Evidences From International Scientific Literature and Pending Questions
    Amodio, Emanuele
    Vitale, Francesco
    Cimino, Livia
    Casuccio, Alessandra
    Tramuto, Fabio
    HEALTHCARE, 2020, 8 (01)